Candida Infections: Epidemiology, Clinical Manifestations and Quality-of-Life Burden
Microbiology Research · 07.08.2026 · 17 (8) · 154
DOI: 10.3390/microbiolres17080154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Research, online erschienen am 07.08.2026. Verfasst von Ana R. Miljković. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Candida infections represent a major global public health challenge and remain among the most common opportunistic fungal infections worldwide. Although Candida albicans remains the predominant pathogen, the incidence of infections caused by non-albicans species, particularly Candidozyma auris, has increased substantially in recent years. Candida infections range from superficial mucocutaneous disease to invasive life-threatening infections associated with high morbidity and mortality. In addition to clinical burden, growing evidence indicates a substantial negative impact on health-related quality of life, particularly among patients with recurrent vulvovaginal candidiasis and chronic fungal infections.
Zitieren
APA
Miljković, A. R. (2026). Candida Infections: Epidemiology, Clinical Manifestations and Quality-of-Life Burden. Microbiology Research, 17(8), 154. https://doi.org/10.3390/microbiolres17080154
Vancouver
Miljković AR. Candida Infections: Epidemiology, Clinical Manifestations and Quality-of-Life Burden. Microbiology Research. 2026;17(8):154. doi:10.3390/microbiolres17080154
BibTeX
@article{Miljkovi2026,
author = {Miljković, Ana R.},
title = {Candida Infections: Epidemiology, Clinical Manifestations and Quality-of-Life Burden},
journal = {Microbiology Research},
year = {2026},
volume = {17},
number = {8},
pages = {154},
doi = {10.3390/microbiolres17080154}
}
EUVIMED